Company appoints Anil K. Sood, MD, as inaugural member Company continues to advance lead program, KAD101 for the treatment of…
NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Sparian Biosciences, Inc. (“Sparian”), a clinical-stage CNS-focused biopharmaceutical company, is proud to…
SAN FRANCISCO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Upwave, the leading analytics platform for brand advertising, today announced the appointment…